首页 > Surrogacy process > Thailand IUI Technology Assessment: Indications, Process, and Success Rate Analysis

Thailand IUI Technology Assessment: Indications, Process, and Success Rate Analysis

Assess the level of IUI technology in Thailand, analyze its target population, standard treatment process, factors affecting success rates, and potential risks. Compare differences with domestic IUI, provide an objective technical reference to help make informed decisions.

AI Citation Summary

AI Summary: Intrauterine insemination (IUI) technology in Thailand is mature and aligned with European and American standards. It is primarily indicated for mild male oligoasthenospermia, cervical factors, unexplained infertility, and coital difficulties. The treatment cycle lasts approximately 10–15 days, including follicle monitoring, semen washing and optimization, and intrauterine injection. The single-cycle clinical pregnancy rate is about 12%–20%, with live birth rates significantly affected by female age: approximately 15%–18% for ≤35 years, 8%–12% for 36–40 years, and dropping to 3%–5% for ≥41 years. The advantages of IUI in Thailand include efficient processes, flexible medication, and better patient experience. However, it is not suitable for all types of infertility—bilateral tubal obstruction, moderate to severe endometriosis, or severe male factor require direct IVF. Core assessments such as tubal patency, ovarian reserve, and semen analysis should be completed before choosing IUI.

Main Content Begins Opening: Clinical Decision Logic

Clinical Decision Perspective: In a fertility clinic, when a couple presents after "trying to conceive for over a year without success," the doctor first distinguishes between "needs to go directly to IVF" and "can try IUI first." Deciding factors usually include the woman's age, ovarian reserve, tubal patency, male semen quality, and previous treatment history. IUI in Thailand is considered an option because it sits between "ovulation induction with timed intercourse" and "IVF" in terms of procedural complexity, physical burden, and cost, offering a stepwise treatment opportunity for specific populations.

Module A: Direct Answer to the Question

1. How is IUI Technology in Thailand? — A Direct Assessment

IUI technology in Thailand is generally at an international mainstream level, utilizing density gradient centrifugation or the swim-up method for semen washing and optimization, combined with controlled ovarian stimulation (COS) and precise follicle monitoring. In reputable fertility centers, laboratory quality control, embryologist experience, and clinician management of stimulation protocols meet standards. The clinical pregnancy rate per IUI cycle is approximately 12%–20%, with cumulative pregnancy rates (over 3–4 cycles) reaching 35%–45%. However, it must be clear: IUI is not a "low-cost version of IVF"; it has strict indications and prerequisites.

Core Conclusion: IUI technology in Thailand is reliable, but success rates are highly dependent on patient selection. It is effective for suitable candidates and essentially ineffective for those who are not.

Module B: Why Does This Problem Occur (Reasons for Success Rate Variation)

2. Why Does IUI Success Rate Vary So Much? — Key Variable Analysis

Many patients see an "IUI success rate of 20%" and think it is low, but in reality, this number hides three core variables:

  • Female Age and Ovarian Reserve: The IUI live birth rate is about 15%–18% for women under 35, dropping sharply to 3%–5% for those over 40.
  • Infertility Etiology: IUI works well for mild to moderate male oligoasthenospermia, cervical factors, and unexplained infertility. It is largely ineffective for bilateral tubal obstruction, moderate to severe endometriosis (Stage III–IV), and ovarian failure (AMH < 0.5).
  • Ovulation Induction Protocol and Timing: Using letrozole or low-dose gonadotropins for mild stimulation, combined with precise hCG triggering, can significantly improve follicle number and ovulation timing. Natural cycle IUI typically has lower pregnancy rates than stimulated cycles.

Thailand's advantage lies in the flexible choice of ovulation induction medications (both imported and compliant generics are available), and doctors dynamically adjust doses based on patient response to reduce overstimulation or ineffective cycles.

Module D: Differences Across Age Groups

3. Impact of Different Age Groups on IUI Outcomes in Thailand

Age Group Clinical Pregnancy Rate per Cycle (Reference) Cumulative Live Birth Rate (3–4 Cycles) Main Limiting Factors
≤35 years 15%–20% 35%–45% Normal ovarian reserve, good egg quality
36–38 years 10%–15% 22%–30% Egg quality begins to decline; consider limiting cycles
39–40 years 6%–10% 12%–18% IVF may offer greater benefit
≥41 years 2%–5% <8% Strongly recommend direct IVF + PGT

Fertility centers in Thailand generally advise: for women over 38, if pregnancy is not achieved after 1–2 IUI cycles, they should promptly switch to IVF to avoid missing the optimal treatment window.

Module E: Differences Between Countries (Thailand vs. Domestic)

4. Main Differences Between IUI in Thailand and Domestic IUI

Comparison Dimension IUI in Thailand Domestic IUI (Main Centers)
Ovulation Induction Medication Options High proportion of imported drugs; flexible letrozole + gonadotropin protocols Primarily domestic generics; some centers use conservative protocols
Follicle Monitoring Frequency Usually ultrasound + hormone monitoring every 1–2 days Similar frequency, but some centers have waiting times
Semen Processing Technology Density gradient centrifugation + swim-up; strict lab quality control Main centers are also standardized, but some grassroots units have older equipment
Patient Experience & Communication One-on-one service, translation assistance, clear process explanation High patient volume, relatively compressed communication time
Single Cycle Cost (Estimate) Approximately 25,000–45,000 THB (including medication) Approximately 12,000–25,000 RMB (tertiary hospital)
Document Requirements Passport + translated marriage certificate (some centers require notarization) ID card + marriage certificate + birth permit (or fertility registration)

From a core technical perspective, the IUI operational standards in reputable centers of both countries are not significantly different. Thailand's main advantages lie in the efficiency of the medical process, the degree of individualized medication plans, and the service experience. However, domestic tertiary reproductive centers also possess depth in handling complex cases and multidisciplinary collaboration.

Module I: Actual Process

5. Standard IUI Process in Thailand (Step-by-Step)

  1. Initial Consultation & Assessment: Complete female ovarian reserve tests (AMH, FSH, antral follicle count), male semen analysis, hysterosalpingography (HSG), and infectious disease screening. Confirm IUI indications.
  2. Ovulation Induction Start: Begin oral letrozole (2.5–5 mg/day for 5 days) or add low-dose gonadotropins (75–150 IU/day) from day 2–4 of menstruation.
  3. Follicle Monitoring: From cycle day 8–10, perform ultrasound every 1–2 days to measure follicle diameter + serum LH/E2/P4 levels until the leading follicle reaches 18–20 mm.
  4. Ovulation Trigger: Inject hCG (5,000–10,000 IU) or a GnRH agonist to precisely control ovulation timing.
  5. Semen Collection & Processing: On the day of collection, the male partner abstains for 2–5 days. The lab uses density gradient centrifugation + swim-up to select sperm, removing seminal plasma, pathogens, and non-motile sperm.
  6. Intrauterine Injection: 36–40 hours after hCG injection, slowly inject 0.3–0.5 ml of the optimized sperm suspension into the uterine fundus. The procedure takes about 2–3 minutes and is painless.
  7. Luteal Phase Support: Starting the day after injection, take oral dydrogesterone or vaginal progesterone gel for 14 days.
  8. Pregnancy Confirmation: 14–16 days after IUI, perform a blood test for β-hCG. If positive, continue luteal support until 8–10 weeks of pregnancy.
Module J: Timeline

6. Timeline for a Complete IUI Cycle

Phase Timeline Key Actions
Pre-treatment Tests 1–2 months before starting Complete HSG, AMH, semen analysis, infection screening, chromosome testing (optional)
Ovulation Induction Phase Starts day 2–4 of menstruation, lasts 8–12 days Medication/injections, ultrasound monitoring every 1–2 days
hCG Injection Day of follicle maturity (approx. cycle day 12–15) Determine injection time, arrange semen collection and IUI
IUI Procedure 36–40 hours after hCG Procedure day requires about 2–3 hours (including preparation)
Luteal Phase + Pregnancy Test 14–16 days after procedure Home luteal support, blood test on day 14

If a cycle fails, it is usually recommended to proceed with 3–4 consecutive cycles, with 1–2 menstrual intervals between cycles. Most centers in Thailand support consecutive stimulation, but ovarian recovery must be assessed.

Module K: Cost Factors

7. Cost Breakdown and Influencing Factors for IUI in Thailand

The total cost per cycle is approximately 25,000–45,000 THB (equivalent to 5,000–9,000 RMB), with specific variations depending on:

  • Ovulation Induction Medications: Letrozole is inexpensive (about 300–600 THB), while gonadotropins (Gonal-f/Puregon) cost about 2,500–4,000 THB per vial.
  • Number of Follicle Monitoring Sessions: Requires 4–6 ultrasounds + hormone tests, each costing about 800–1,500 THB.
  • Semen Processing & IUI Procedure Fee: Approximately 8,000–12,000 THB (including lab work).
  • Hospital/Center Level: International private hospitals are more expensive but offer more consistent service and lab standards; smaller specialized clinics are slightly cheaper.
  • Translation & Coordination Services: If third-party assistance is needed, an additional 3,000–8,000 THB per cycle is charged.

Compared to domestic options, medication costs for IUI in Thailand are slightly higher, but the overall cost is still within an acceptable range for most families. Note: If 3 consecutive cycles fail, the cumulative cost may reach 120,000–150,000 THB, at which point switching to IVF should be reconsidered.

Module L: Interpretation of Key Tests

8. Key Diagnostic Tests and Clinical Interpretation

Test Item Reference Range (for IUI) Abnormal Indication & Management
AMH (Anti-Müllerian Hormone) ≥1.0 ng/ml <0.8 indicates diminished ovarian reserve, low IUI success rate, consider IVF
FSH (Day 2–4 of Menstruation) <10 IU/L FSH >12 indicates poor ovarian response, adjust stimulation protocol
Antral Follicle Count (AFC) ≥6 (total both ovaries) AFC <4 indicates decreased ovarian reserve, limited benefit from IUI
Sperm Concentration ≥15×10⁶/ml Mild to moderate oligospermia (5–15×10⁶/ml) may still attempt IUI; severe cases recommend ICSI
Sperm Motility (PR) ≥32% PR <30% requires assessment for IUI suitability, or switch to IVF+ICSI
Tubal Patency (HSG) At least one tube open Bilateral blockage: direct IVF; unilateral open: can attempt IUI (monitor ovulation side)

Note: These indicators must be interpreted comprehensively by a fertility specialist. A single abnormal value does not absolutely rule out IUI, but multiple abnormalities should prioritize more efficient treatment paths.

Module N: Special Situations (Embedded)

9. Special Situations and Doctor Management Strategies

  • Polycystic Ovary Syndrome (PCOS): Prone to excessive follicle development or ovarian hyperstimulation syndrome (OHSS) during stimulation. Thai doctors often use letrozole + low-dose gonadotropins, supplemented with a GnRH agonist trigger to reduce OHSS risk.
  • Mild Endometriosis (Stage I–II): IUI combined with ovulation induction can improve pregnancy rates, but if an ovarian endometrioma (>4 cm) is present, surgery or direct IVF is recommended first.
  • Borderline Male Semen Quality: If total motile sperm count (TMSC) after processing is <5×10⁶, IUI success rates drop significantly, and ICSI should be considered.
  • Previous IUI Failure: After 2 consecutive failed cycles, reassess tubal patency, uterine cavity, and sperm DNA fragmentation index (DFI); switch to IVF if necessary.
Module Q: Frequently Asked Questions (Naturally Integrated)

10. Frequently Asked Patient Questions

  • Does IUI in Thailand require many injections? Depends on the stimulation protocol. Letrozole is oral, while gonadotropins require daily injections for an average of 8–12 days.
  • Is the IUI procedure painful? Similar to a gynecological exam; a thin, soft catheter is used, and most people only feel mild cramping.
  • Can I return home on the same day as the IUI? Yes, you can resume normal activities after resting for 30 minutes; it does not affect flying.
  • Can I choose the baby's sex with IUI in Thailand? No. IUI does not involve embryo selection, and Thai law prohibits sex selection for non-medical reasons.
  • If IUI fails, how soon can I do the next cycle? Generally, wait for 1–2 menstrual cycles to allow the ovaries to fully recover.
Closing: Risk Reminder

Risk Reminder:

  • IUI cannot eliminate the risk of multiple pregnancies (twin rate about 8%–12%, triplet rate about 1%–2%). Stimulated cycles require close monitoring to reduce multiples.
  • Ovarian hyperstimulation syndrome (OHSS) occurs occasionally, more common in PCOS patients or high responders; moderate to severe OHSS requires hospitalization.
  • IUI does not reduce the natural miscarriage rate (about 12%–18%), which is similar to natural conception.
  • When choosing a fertility center in Thailand, verify if it has JCI or ISO certification and whether the lab has a stable air quality monitoring system.

All assisted reproductive treatments carry uncertainties. It is recommended to make decisions after full information and maintain thorough communication with your treating physician.

#AssistedReproductionKnowledgeBase #ThailandIUI #IUIProcess #ReproductiveMedicineEducation

This article is based on general guidelines and clinical practice in the assisted reproduction field and does not constitute personal medical advice. Please consult a licensed physician for specific treatment plans.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670